This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Enzo Life Sciences
other brands :
Stressgen, BioMol, Alexis Corporation, Assay Designs, Alexis
product type :
secondary antibody
product name :
Mouse IgG2a isotype control, monoclonal antibody (C1.18) (FITC conjugate)
catalog :
ADI-SAB-601FI-200
quantity :
200 µg
product information
Product ID :
ADI-SAB-601FI
Catalog Number :
ADI-SAB-601FI-200
Product Name :
Mouse IgG2a isotype control, monoclonal antibody (C1.18) (FITC conjugate)
Host species :
Mouse
Clonality :
Monoclonal
Conjugation :
FITC
Product Type :
Antibody
Size :
200 µg
Clone :
C1.18
Isotype :
IgG2a
SPECIES REACTIVITY :
Species independent
Background :
Isotype matched controls are useful in flow cytometry to determine a gross estimate of non-specific binding that may be observed with a specific antibody of interest. In general, an isotype control should be of the same species and isotype as the antibody of interest, used at the same concentration, and conjugated to the same fluorophore. This reagent is an IgG2a isotype mouse monoclonal antibody (Clone # C1.18), conjugated to FITC. It is intended for use as an isotype control antibody for flow cytometry.
Buffer :
Liquid. In PBS, pH 7.2, containing 0.09% sodium azide.
Application Summary :
FC
Storage :
+4°C
company information
Enzo Life Sciences
5777 Hines Drive
Ann Arbor, MI 48108
Ann Arbor, MI 48108
info-us@enzolifesciences.
https://www.enzolifesciences.com1-800-942-0430
headquarters: USA
Enzo Life Sciences, incorporating ALEXIS® Biochemicals and BIOMOL® International, offers a comprehensive panel of innovative life science reagents. Antibodies, enzymes, proteins, small molecule inhibitors, product libraries, and assay kits are available for research in Cancer, Cell Death, Epigenetics, Genomics, Immunology, Neuroscience, Signal Transduction, and Ubiquitin & Proteasomes, Enabling Discovery in Life Science(tm). Visit www.enzolifesciences.com.
questions and comments